Low-Dose Ponatinib Is A Good Option In Chronic Myeloid Leukemia Patients Intolerant To Previous Tkis

Caocci, Giovanni;
2020-01-01
2020
Files in This Item:
File Size Format  
LOW-DOSE PONATINIB IS A GOOD OPTION IN CHRONIC MYELOID LEUKEMIA PATIENTS INTOLERANT TO PREVIOUS TKIs .pdf

Solo gestori archivio

Type: versione pre-print
Size 957.76 kB
Format Adobe PDF
& nbsp; View / Open   Request a copy
957.76 kB Adobe PDF & nbsp; View / Open   Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Questionnaire and social

Share on:
Impostazioni cookie